The second WMC Newsletter includes a review of what 2023 might mean for the Italian wound care market, New German Nursing Qualifications, New Technologies is development and a snap shot of French wound care market stats,
Skin substitutes have been a part of the wound treatment armamentarium of medical practitioners for over 20 years, yet widespread adoption of these products in the US and other countries did not take off until just a few years ago.
Much has been written about the centrality of the patient’s own experience to the delivery of the care of their chronic wound. Their importance as stakeholder and actor in their own treatment is recognised but in many countries they remain without their own lobbying and self-help organisation.
The first Wound Market Consulting Newsletter of 2023 includes the extension of nurses decision making authority in Poland and Belgium, pharma’s interest in wound care and current clinical trials underway.
Andrew Adams of WMC and Mark Campbell (EX-NICE Associate/Programme Director, 2010-2019) discussed what MedTech companies hoping for NICE Guidance for the UK National Health Service (NHS) should and shouldn’t do.
Second in the Meet the Team series we introduce Dr Jirí Létal, Statistician.
An analysis of the Business Register dedicated to SUi (Innovative Start Ups) and SMEi (Innovative Small Medium
Enterprises) identified twenty companies engaged in various areas of wound care
In the first of the Meet the Team series, we introduce Jonathan Hughes PhD, Regulatory Affairs Professional
Andrew Adams of Wound Market Consulting interviewed Dr Eberlein as part of the Wound Care Survey series.
Wound Market Consulting has embarked upon a short series of interviews of international clinicians to provide an insight
into how they prioritise advanced technologies.
